(2S,2'S)-2,2'-(((S)-6-((S)-2-carboxypyrrolidin-1-yl)-6-oxohexane-1,5-diyl)bis(azanediyl))bis(4-phenylbutanoic acid)
Lisinopril EP Impurity I is a fully characterized chemical compound used as a reference standard of API Lisinopril. The standard offered is compliant with regulatory guidelines. Lisinopril EP Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
N-(1-Carboxy-3-phenylpropyl)-S-lisinopril Trisodium Salt (Mixture of diastereomers)
M.F. C₃₁H₃₈N₃O₇Na₃
M.W. 633.67
CAT# AR-L06104
CAS# NA
Lisinopril Impurity H (Dimer Impurity, Mixture of Diastereomers)
M.F. C₃₇H₅₃N₅O₈
M.W. 695.86
CAT# AR-L01752
CAS# NA
Lisinopril EP Impurity G (Dimer Impurity)
M.F. C₄₂H₆₀N₆O₉
M.W. 792.98
CAT# AR-L01753
CAS# 1356839-89-8
(S)-Lisinopril Dihydrate
M.F. C₂₁H₃₁N₃O₅; ₂H₂O
M.W. 405.50; 2(18.01)
CAT# AR-L05932
CAS# 83915-83-7 (dihydrate)
